Amneal Pharmaceuticals, Inc. Stock News

New York State Common Retirement Fund grew its position in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 24.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and E

Investors who take an interest in Amneal Pharmaceuticals, Inc. (NYSE:AMRX) should definitely note that insider Joseph...

Zacks Investment Research upgraded shares of Amneal Pharmaceuticals (NYSE:AMRX) from a strong sell rating to a hold rating in a research note published on Tuesday morning, Zacks.com reports. According

Amneal Pharmaceuticals Inc (NYSE:AMRX)’s stock price traded up 7.1% on Wednesday after an insider bought additional shares in the company. The stock traded as high as $4.17 and last traded at $4.09,

Amneal Pharmaceuticals Inc (NYSE:AMRX) SVP Joseph Todisco acquired 40,000 shares of Amneal Pharmaceuticals stock in a transaction that occurred on Friday, February 28th. The stock was purchased at an

Amneal Pharmaceuticals Inc (NYSE:AMRX) shot up 7.1% during trading on Wednesday after an insider bought additional shares in the company. The company traded as high as $4.17 and last traded at $4.09,

The online pharmacy conducted its own tests of the type-2 diabetes drug and found excessive levels of a carcinogenic compound in 42% of the batches it tested.

Online pharmacy Valisure said on Monday its tests showed high levels of a probab...

Amneal Pharmaceuticals (NYSE:AMRX) had its price target reduced by SunTrust Banks from $6.00 to $5.00 in a research report released on Thursday morning, BenzingaRatingsTable reports. SunTrust Banks cu

Amneal Pharmaceuticals Inc (NYSE:AMRX) – SunTrust Banks decreased their Q2 2020 EPS estimates for shares of Amneal Pharmaceuticals in a research note issued to investors on Wednesday, February 26th.

Amneal Pharmaceuticals Inc (NYSE:AMRX) – Piper Sandler cut their Q1 2020 earnings per share (EPS) estimates for shares of Amneal Pharmaceuticals in a report issued on Wednesday, February 26th. Piper

American International Group Inc. boosted its holdings in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 25.1% during the fourth quarter, according to the company in its most recent Form 13F fili

Amneal Pharmaceuticals (NYSE:AMRX) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, ValuEngine re

Amneal Pharmaceuticals Inc (NYSE:AMRX) was the target of a large drop in short interest during the month of February. As of February 14th, there was short interest totalling 3,940,000 shares, a drop o

California Public Employees Retirement System grew its stake in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 66.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The fir